Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT02226965 is registered in ClinicalTrials.gov with Sierra Oncology LLC - a GSK company as lead sponsor.

NCT NCT02226965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02226965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Lead sponsor
Sierra Oncology LLC - a GSK company
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
August 22, 2018
Enrollment
45 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, diffuse large b-cell